EUVIMEDOpdag EUVIMED
Systematische ÜbersichtOpen access

The Use of Machine Learning for Analyzing Real-World Data in Disease Prediction and Management: Systematic Review

Einsatz von Machine Learning zur Analyse von Real-World Data in Krankheitsvorhersage und -management: systematische Übersichtsarbeit

Norah Hamad Alhumaidi iD, Doni Dermawan iD, Hanin Farhana Kamaruzaman iD, Nasser Alotaiq iD

JMIR Medical Informatics · 2025-06-19 · 13 · e68898

DOI: 10.2196/68898 ↗

Auf einen Blick

Die Übersichtsarbeit zu 57 Studien zeigt breite Nutzung von ML für Krankheitsvorhersage und -management mit Schwerpunkt auf prädiktiven Modellen. Häufig genannt wurden random forest, logistische Regression und Support Vector Machines.

Fragestellung

Welche ML-Methoden, Krankheitsbereiche, Studiendesigns und Quellen von Real-World Evidence werden bei der Analyse von Real-World Data in Krankheitsvorhersage und -management verwendet?

Methode

Systematische Übersichtsarbeit nach PRISMA; Suche nach Studien von 2014 bis 2024; erfasst wurden ML-Algorithmen, Krankheitskategorien, Studiendesigns und RWE-Quellen.

Ergebnisse

57 Studien mit insgesamt >150.000 Patient:innen. Häufigste ML-Methoden: random forest (n=24, 42 %), logistische Regression (n=21, 37 %), Support Vector Machines (n=18, 32 %).

Einschränkungen

Viele Studien hatten Probleme mit Datenqualität, Interpretierbarkeit der Modelle und Generalisierbarkeit (n=34, 60 %).

Schlussfolgerung der Autor:innen

Die Autor:innen heben das große Potenzial von ML und Big Data für Krankheitsvorhersage und -management hervor, betonen aber die Notwendigkeit, Datenqualität, Transparenz und Übertragbarkeit zu verbessern.

Kernaussagen

  • 57 Studien mit >150.000 Patient:innen
  • Häufig: random forest, logistische Regression, SVM
  • Herausforderungen: Datenqualität, Transparenz, Generalisierbarkeit

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Systematische Übersicht in JMIR Medical Informatics, published online on 2025-06-19. Written by Norah Hamad Alhumaidi and 3 co-authors. Institution: College of Medicine, Qassim University, Buraidah, Saudi Arabia. Major MEDLINE topics: Disease Management, Machine Learning. Cited 72 times so far (Crossref); 121 references. The full text is freely available in PubMed Central.

Auf einen BlickAbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Machine learning (ML) and big data analytics are rapidly transforming health care, particularly disease prediction, management, and personalized care. With the increasing availability of real-world data (RWD) from diverse sources, such as electronic health records (EHRs), patient registries, and wearable devices, ML techniques present substantial potential to enhance clinical outcomes. Despite this promise, challenges such as data quality, model transparency, generalizability, and integration into clinical practice persist.

Objective

This systematic review aims to examine the use of ML for analyzing RWD in disease prediction and management, identifying the most commonly used ML methods, prevalent disease types, study designs, and the sources of real-world evidence (RWE). It also explores the strengths and limitations of current practices, offering insights for future improvements.

Methods

A comprehensive search was conducted following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines to identify studies using ML techniques for analyzing RWD in disease prediction and management. The search focused on extracting data regarding the ML algorithms applied; disease categories studied; types of study designs (eg, clinical trials and cohort studies); and the sources of RWE, including EHRs, patient registries, and wearable devices. Studies published between 2014 and 2024 were included to ensure the analysis of the most recent advances in the field.

Results

This review identified 57 studies that met the inclusion criteria, with a total sample size of >150,000 patients. The most frequently applied ML methods were random forest (n=24, 42%), logistic regression (n=21, 37%), and support vector machines (n=18, 32%). These methods were predominantly used for predictive modeling across disease areas, including cardiovascular diseases (n=19, 33%), cancer (n=9, 16%), and neurological disorders (n=6, 11%). RWE was primarily sourced from EHRs, patient registries, and wearable devices. A substantial portion of studies (n=38, 67%) focused on improving clinical decision-making, patient stratification, and treatment optimization. Among these studies, 14 (25%) focused on decision-making; 12 (21%) on health care outcomes, such as quality of life, recovery rates, and adverse events; and 11 (19%) on survival prediction, particularly in oncology and chronic diseases. For example, random forest models for cardiovascular disease prediction demonstrated an area under the curve of 0.85 (95% CI 0.81-0.89), while support vector machine models for cancer prognosis achieved an accuracy of 83% (P=.04). Despite the promising outcomes, many (n=34, 60%) studies faced challenges related to data quality, model interpretability, and ensuring generalizability across diverse patient populations.

Conclusions

This systematic review highlights the significant potential of ML and big data analytics in health care, especially for improving disease prediction and management. However, to fully realize the benefits of these technologies, future research must focus on addressing the challenges of data quality, enhancing model transparency, and ensuring the broader applicability of ML models across diverse populations and clinical settings.

Subjects

MeSH terms (MEDLINE)

Disease ManagementMachine LearningHumansBig DataElectronic Health Records

Author keywords

AIartificial intelligencebig datadisease predictionhealth care managementmachine learningreal-world datareal-world evidence

Authors and institutions

  • College of Medicine, Qassim University, Buraidah, Saudi Arabia.
  • Applied Biotechnology, Faculty of Chemistry, Warsaw University of Technology, Warsaw, Poland.
  • Malaysian Health Technology Assessment Section, Medical Development Division, Ministry of Health Malaysia, Wilayah Persekutuan Putrajaya, Malaysia.
  • Health Economics and Health Technology Assessment, School of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.
  • Health Sciences Research Center, Imam Mohammad ibn Saud Islamic University, Riyadh, Saudi Arabia.

ORCID profiles: Norah Hamad Alhumaidi, Doni Dermawan, Hanin Farhana Kamaruzaman, Nasser Alotaiq

Cite

APA

Alhumaidi, N. H., Dermawan, D., Kamaruzaman, H. F., & Alotaiq, N. (2025). The Use of Machine Learning for Analyzing Real-World Data in Disease Prediction and Management: Systematic Review. JMIR Medical Informatics, 13, e68898. https://doi.org/10.2196/68898

Vancouver

Alhumaidi NH, Dermawan D, Kamaruzaman HF, Alotaiq N. The Use of Machine Learning for Analyzing Real-World Data in Disease Prediction and Management: Systematic Review. JMIR Medical Informatics. 2025;13:e68898. doi:10.2196/68898

BibTeX
@article{Alhumaidi2025,
  author = {Alhumaidi, Norah Hamad and Dermawan, Doni and Kamaruzaman, Hanin Farhana and Alotaiq, Nasser},
  title = {The Use of Machine Learning for Analyzing Real-World Data in Disease Prediction and Management: Systematic Review},
  journal = {JMIR Medical Informatics},
  year = {2025},
  volume = {13},
  pages = {e68898},
  doi = {10.2196/68898}
}
Start for free →